| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/02/2013 | EP2643462A1 Inhibitors of sp140 and their use in therapy |
| 10/02/2013 | EP2643354A1 Novel homogeneous humanized antiproliferation antibodies |
| 10/02/2013 | EP2643350A2 Nk cell modulating treatments and methods for treatment of hematological malignancies |
| 10/02/2013 | EP2643322A1 Salts and crystalline forms of an apoptosis-inducing agent |
| 10/02/2013 | EP2643321A1 Imidazo [1,2-b]pyridazine and imidazo [4,5-b]pyridine derivatives as jak inhibitors |
| 10/02/2013 | EP2643315A1 BENZOXAZEPINES AS INHIBITORS OF P13K/mTOR AND METHODS OF THEIR USE AND MANUFACTURE |
| 10/02/2013 | EP2643314A1 Novel salts and polymorphic forms of afatinib |
| 10/02/2013 | EP2643301A1 Technetium-99m complex as a tool for the in vivo diagnosis of cancerous tumours |
| 10/02/2013 | EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds |
| 10/02/2013 | EP2643057A1 An implant for the controlled release of pharmaceutically active agents |
| 10/02/2013 | EP2643024A1 177lutetium-labeled bombesin analogs for radiotherapy |
| 10/02/2013 | EP2643018A2 Anti-il-6 antibodies for the treatment of oral mucositis |
| 10/02/2013 | EP2643010A2 Biologically active complex and its preparation |
| 10/02/2013 | EP2642986A2 Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapy |
| 10/02/2013 | EP2642979A1 A pharmaceutical composition |
| 10/02/2013 | CN203220605U Quick-acting tumor pain relieving bag |
| 10/02/2013 | CN103339253A TOMM34 peptides and vaccines including the same |
| 10/02/2013 | CN103339150A Anti-bradykinin B2 receptor (BKB2R) monoclonal antibody |
| 10/02/2013 | CN103339139A 7-deazapurine modulators of histone methyltransferase, and methods of use thereof |
| 10/02/2013 | CN103339134A Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors |
| 10/02/2013 | CN103339132A Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredi |
| 10/02/2013 | CN103339129A Derivatives of azaindazole or diazaindazole type as medicament |
| 10/02/2013 | CN103339117A 1,4 oxazines as bace1 and/or bace2 inhibitors |
| 10/02/2013 | CN103339115A Metalloenzyme inhibitor compounds |
| 10/02/2013 | CN103339110A Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses |
| 10/02/2013 | CN103339107A Novel azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 10/02/2013 | CN103338787A Microsphere comprising a lanthanide metal complex |
| 10/02/2013 | CN103338781A Compositions and methods of aloe polysaccharides |
| 10/02/2013 | CN103338779A Pharmaceutical composition for treating cancer |
| 10/02/2013 | CN103338751A A pharmaceutical composition |
| 10/02/2013 | CN103338659A Method for utilizing extraction residue of yeast extract |
| 10/02/2013 | CN103333896A Nucleic acid aptamer LXL-1 of breast cancer cell MDA-MB-231 and application thereof |
| 10/02/2013 | CN103333895A Nucleic acid aptamer specifically binding to human epidermal growth factor acceptor III type mutant and applications thereof |
| 10/02/2013 | CN103333893A sHRNA (short hairpin ribonucleic acid) for inhibiting expression of human oral cancer cell PRPS2 (phosphoribosyl pyrophosphate synthetase subunit II) as well as construction and application of carrier of sHRNA |
| 10/02/2013 | CN103333892A Small interference RNA aiming at HPV16E7 gene, and application thereof |
| 10/02/2013 | CN103333891A Small interference RNA aiming at HPV16E7 gene, and application thereof |
| 10/02/2013 | CN103333875A Marine phasolosma esculenta fibrinolytic enzyme, preparation method and applications thereof |
| 10/02/2013 | CN103333860A Cells producing antibody compositions |
| 10/02/2013 | CN103333267A Enteromorpha se-polysaccharide with biological activity as well as preparation method and application of enteromorpha se-polysaccharide |
| 10/02/2013 | CN103333249A PSMA (Prostate Specific Membrane Antigen) monoclonal antibody and applications thereof |
| 10/02/2013 | CN103333247A Novel monoclonal antibody of VEGFR2 and preparation and application thereof |
| 10/02/2013 | CN103333246A Anti-EGFR tumor growth inhibitor, preparation method thereof and applications thereof |
| 10/02/2013 | CN103333245A Anti-cell-acceptor and anti-tumor-growth drug molecule, preparation method thereof and applications thereof |
| 10/02/2013 | CN103333227A Metastatic tumor deletion protein small-molecule cyclopeptide inhibitor as well as preparation method and application thereof |
| 10/02/2013 | CN103333217A Compound having quinone reductase induced activity and preparation method thereof |
| 10/02/2013 | CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof |
| 10/02/2013 | CN103333176A Norlignan compounds and method of separating and verifying norlignan compounds from pouzolzia zeylanica var. microphylla |
| 10/02/2013 | CN103333172A Camptothecin thiosemicarbazone compound and preparation method and use thereof |
| 10/02/2013 | CN103333161A Preparation method and use of 1'-oxo-indirubin |
| 10/02/2013 | CN103333157A Pyridine carboxamide derivative as kinase inhibitor |
| 10/02/2013 | CN103333153A A novel compound sciryagarol II having antineoplastic and antibiosis activities and a preparation method thereof |
| 10/02/2013 | CN103333140A Preparation method of curcumin derivatives, and antitumor drug |
| 10/02/2013 | CN103333138A Novel Cabazitaxel crystal form, preparation method, application and pharmaceutical compositions thereof |
| 10/02/2013 | CN103333132A N-(4-tertbutyl-5-benzyl thiazole-2-yl)amide and preparation method and application thereof |
| 10/02/2013 | CN103333119A 1,2-dihydro-6-methyl-4-substituted amino-5-pyrimidinecarboxylic acid compound and its preparation method and use |
| 10/02/2013 | CN103333071A 10-benzylideneanthrone compound and application thereof |
| 10/02/2013 | CN103330952A <131>I-labeled vascular endothelial growth factor receptor2 (VEGFR2)-resistant chimeric Fab and use thereof |
| 10/02/2013 | CN103330945A Application of pingyangmycin combined with sodium hyaluronate in drug for treating lymphatic malformation |
| 10/02/2013 | CN103330941A Pharmaceutical composition of paclitaxel injection |
| 10/02/2013 | CN103330940A Combined preparation and application of combined preparation in preparing non-small-cell lung carcinoma drug |
| 10/02/2013 | CN103330938A Tumor targeting photosensitizers and preparation methods and applications of photosensitizers |
| 10/02/2013 | CN103330937A Monoclonal antibody-antigen binding segment-T-2 toxin conjugate |
| 10/02/2013 | CN103330921A Formula of traditional Chinese medicine for treating cancer and rheumatism |
| 10/02/2013 | CN103330894A 中药组合物及其制备方法 Chinese medicine composition and its preparation method |
| 10/02/2013 | CN103330818A Fungus electuary and preparation method thereof |
| 10/02/2013 | CN103330807A Natural drug composite, and preparation method and purpose thereof |
| 10/02/2013 | CN103330791A Anti-cancer Chinese herbal medicine formula with Lysimachia capillipes Hemsl as main body |
| 10/02/2013 | CN103330787A Natural medicine extractive |
| 10/02/2013 | CN103330781A Traditional Chinese medicine composite with anti-tumor effect and preparation method of injection of same |
| 10/02/2013 | CN103330773A Natural Chinese medicine composition |
| 10/02/2013 | CN103330771A Treatment of lung cancer through oral use of fresh urine and a traditional Chinese medicine capsule |
| 10/02/2013 | CN103330753A Traditional Chinese medicine composition and preparation method thereof |
| 10/02/2013 | CN103330752A Natural medicine composition, preparation method and purpose of natural medicine composition |
| 10/02/2013 | CN103330751A Natural medicinal composition and preparation method and application thereof |
| 10/02/2013 | CN103330746A Traditional Chinese medicine composition, and preparation method and application thereof |
| 10/02/2013 | CN103330745A Natural pharmaceutical composition |
| 10/02/2013 | CN103330730A Natural medicine composition and preparation method thereof |
| 10/02/2013 | CN103330723A Applications of genetically engineered respiratory syncytial virus ([delta]NS1 RSV) in medicines treating cancer |
| 10/02/2013 | CN103330720A Mixing stem cell injection and preparation method thereof |
| 10/02/2013 | CN103330713A Application of Aspeverin in preparation of medicine for treating tongue cancer |
| 10/02/2013 | CN103330694A Oral formulations |
| 10/02/2013 | CN103330686A Freeze-dried powder injection for injection of chick embryo polysaccharide and preparation method thereof |
| 10/02/2013 | CN103330680A Nano drug transdermal preparation and preparation method thereof |
| 10/02/2013 | CN102716417B Traditional Chinese medicine preparation for treating gynaecopathia and preparation method of preparation |
| 10/02/2013 | CN102488910B Application of radioisotope-marked sunshine anthrone compound in preparing anti-tumor medicine |
| 10/02/2013 | CN102260712B Construction and application of type B adenovirus hominis Ad11 mutant with enhanced tumor dissolving ability |
| 10/02/2013 | CN102258773B Mesylate protein kinase receptor EphA2 dominant epitope compound and preparation method and application thereof |
| 10/02/2013 | CN102058646B Ginsenoside rh2 extract and preparation method thereof |
| 10/02/2013 | CN101948488B Ruthenium-selenium coordination compound and application thereof in preparing fluorescent probe and antineoplastic medicine |
| 10/02/2013 | CN101528256B Use of anti-CD151 antibody in treatment of cancer |
| 10/01/2013 | US8546524 Smoothened polypeptides and methods of use |
| 10/01/2013 | US8546424 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
| 10/01/2013 | US8546407 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors |
| 10/01/2013 | US8546400 1,3-Oxazole-4-carboxamides, 1,3-Thiazole-4-carboxamides, and 1,3-Imidazole-d-carboxamides as Inhibitors of cyclin Dependent kinases |
| 10/01/2013 | US8546396 N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators |
| 10/01/2013 | US8546376 Pharmaceutical compounds |
| 10/01/2013 | US8546366 Method for inhibition of tumor cell growth using (22R)-5α-lanosta-8,24-dien-3β,15α,21-triol |
| 10/01/2013 | US8546346 Methods to reprogram splice site selection in pre-messenger RNAs |
| 10/01/2013 | US8546143 Compositions and methods for inhibiting expression of a target gene |
| 10/01/2013 | US8545897 Pyrrolopyridines as kinase inhibitors |